Logo image
Sign in
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: Results from REDUCE-IT
Journal article   Open access

Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: Results from REDUCE-IT

Pascal M Burger, Deepak L Bhatt, Jannick A. N Dorresteijn, Stefan Koudstaal, Arend Mosterd, Fabrice M. A. C Martens, Philippe Gabriel Steg, Frank L. J Visseren, Joanne Ladner, Lily Kakish, …
European Heart Journal - Cardiovascular Pharmacotherapy, Vol.10(6)
2024

Abstract

Aged Atherosclerosis Biomarkers Double-Blind Method Dyslipidemias Eicosapentaenoic Acid Female Heart Disease Risk Factors Humans Hypolipidemic Agents Lipid Regulating Agents Male Middle Aged Myocardial Infarction Risk Assessment Time Factors Treatment Outcome Triglycerides C reactive protein high density lipoprotein cholesterol icosapentaenoic acid icosapentaenoic acid ethyl ester low density lipoprotein cholesterol triacylglycerol agents affecting lipid metabolism antilipemic agent biological marker icosapentaenoic acid icosapentaenoic acid ethyl ester triacylglycerol abdominal aortic aneurysm adult Article cardiovascular disease cardiovascular mortality cerebrovascular accident controlled study coronary atherosclerosis diabetes mellitus female follow up heart infarction human major adverse cardiac event major clinical study male middle aged peripheral arterial disease risk factor aged atherosclerosis blood clinical trial diagnosis double blind procedure drug therapy dyslipidemia Epidemiology heart disease risk factor mortality multicenter study prevention and control randomized controlled trial risk assessment time factor treatment outcome
url
https://doi.org/10.1093/ehjcvp/pvae030View
Published (Version of record) Open

Metrics

1 Record Views

Details

Logo image